LYN101 safety study in healthy adults and postmenopausal women
Part of Injuries & trauma clinical trials.
This trial tests a new drug called LYN101 to see if it is safe and how it works in healthy adults and in postmenopausal women with low bone mass. It may help strengthen bones in women at risk for osteoporosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- If you are under 50, you must be between 18 and 65 years old. If you are over 50, you must be a woman between 50 and 70.
- Women must have gone through menopause naturally (no period for at least 2 years) or had both ovaries removed at least 2 years ago.
- You must have low bone mass (T-score between -1.0 and -2.5) in your lower spine or hip on a DXA scan.
- You cannot have taken certain bone medications (like bisphosphonates) within the last year or certain steroids within the last two months.
- You must have normal kidney function and your vitamin D level must be at least 20 ng/mL (or you must be willing to take a supplement).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies AGN1 LOEP, a treatment being tested to improve bone strength in people with osteoporosis-related bone loss in the hip. If you qualify, you would be followed over time with clinic visits and testing to see how the treatment affects your bone health.
This study tests how safe and tolerable a new drug, KSHN001034, is in healthy women who have gone through menopause. It involves multiple doses to see how your body processes the medicine.
This trial looks at how exercise, alone or with osteoporosis medication, affects bone health in women after menopause. It may help you find a safe way to strengthen your bones.
This trial tests a new drug, TL-001, in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult between 18 and 55.
This trial tests a new medication, QL1206, against an approved drug, Prolia, to see if it works as well for treating osteoporosis in postmenopausal women. You may be eligible if you have low bone density and at least one risk factor for fractures.
This study tests the safety of a new medicine called IMC-003. It is for healthy women who have gone through menopause. You may be able to join if you are between 45 and 75 years old and meet certain health criteria.
Hear when a new Osteoporotic Fracture trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.